Semaglutide is gaining traction as a novel treatment for type 2 diabetes. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and suppressing https://alexiajyeo237882.ka-blogs.com/88941453/understanding-semaglutide-a-comprehensive-guide